Pijus Barman, PhD, received his doctorate in immunology at the Institute of Life Sciences (ILS), in Bhubaneswar, India. While at ILS, he studied mutual regulation of inflammatory responses by danger associated molecular patterns and pathogen associated molecular patterns. Before joining the Goodridge Lab at Cedars-Sinai, he worked as a postdoctoral research associate at the University of Illinois at Chicago in the lab of Timothy Koh, PhD, where Barman studied myelopoiesis during diabetic wound healing. He is currently developing new models to study pathways of myeloid cell production and the origins of functionally distinct monocyte subsets in healthy aging and in the context of infection and inflammation.
Muhammad Ghauri graduated with his bachelor's degree from the University of Washington in Seattle. He subsequently conducted research into gene editing in immune cells with David Rawlings, MD, at the Seattle Children's Research Institute. Ghauri was previously involved in research into chemotherapeutic delivery for pancreatic ductal adenocarcinoma with Sunil Hingorani, MD, PhD, at the Fred Hutchinson Cancer Research Center in Seattle, and novel imaging and electrode placement techniques for deep brain stimulation with Ryder Gwinn, MD, at the Swedish Neuroscience Institute, Seattle.
Dalton Stamps earned his bachelor's degree in biotechnology from California State Polytechnic University, Pomona. He previously investigated the effects of cytokines on T cell differentiation in irritable bowel disease, as well as the role of the transcription factor Batf3 in fat deposits and fat-associated immune cells in the Michelsen Lab at Cedars-Sinai.
Ying Wang, MD, PhD, is a visiting scientist from the Second Hospital of Hebei Medical University (SHHMU), China. She completed her clinical and research training at the Hebei Medical University in Shijiazhuang, Hebei Province, where she studied apoptosis and proliferation changes in leukemic cells with Ling Pan, MD, PhD, at the Hebei Institute of Hematology. Wang previously worked as a visiting physician with Xiaojun Huang, MD, PhD, in the Hematopoietic Stem Cell Transplantation Centre at Peking University, and is currently an associate senior physician in the Hematology Department at SHHMU. Wang is visiting Cedars-Sinai with a fellowship from the Hebei Provincial Department of Human Resources and Social Security and the SHHMU. She is particularly interested in how myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) modulate myeloid-derived suppressor cells to suppress anti-leukemia immune responses and promote MDS/AML growth.
Anja Wolf earned her bachelor's degree in cellular and molecular biology from California State University, Chico, where she studied hematopoiesis in the laboratory of David Stachura, PhD. She is now pursuing a collaborative PhD thesis research project in the Goodridge and Berman Laboratories, performing epigenetic and single-cell transcriptomic studies to define mechanisms of myeloid cell differentiation and functional programming. Wolf is particularly interested in how tumors modulate myelopoiesis to suppress anti-tumor immune responses and promote tumor growth.
Lab Project: Defining pathways and mechanisms of myeloid cell differentiation
Currently: Assistant Professor of Biomedical Sciences and Principal Investigator of the Yáñez Laboratory at Cedars-Sinai
Currently: Postdoc at University of Southern California
Currently: Postdoc at University of California, San Francisco
Currently: Associate scientist at Xencor
Currently: PhD student at University of California, Riverside